Latest Articles

Publication Date
All News Scientific
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - BioSpace

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer BioSpace

Published: Dec. 6, 2024, 8:22 a.m.
Read Full Article
Supporting Students To Learn More About Pelvic Pain - Mirage News

Supporting Students To Learn More About Pelvic Pain Mirage News

Published: Dec. 6, 2024, 6:08 a.m.
Read Full Article
Study links depression to increased menstrual pain - Contemporary Pediatrics

Study links depression to increased menstrual pain Contemporary Pediatrics

Published: Dec. 5, 2024, 9:08 p.m.
Read Full Article
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - The Malaysian Reserve

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer The Malaysian Reserve

Published: Dec. 5, 2024, 3:36 p.m.
Read Full Article
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - Canada NewsWire

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer Canada NewsWire

Published: Dec. 5, 2024, 2:43 p.m.
Read Full Article
Your periods are more likely to be painful if you have this seemingly unrelated condition - MSN

Your periods are more likely to be painful if you have this seemingly unrelated condition MSN

Published: Dec. 5, 2024, 6:27 a.m.
Read Full Article
Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update comes in li - Defense World

Karyopharm Therapeutics Provides Regulatory Update on Endometrial Cancer ProgramOn December 3, 2024, Karyopharm Therapeutics Inc. released a press statement outlining a regulatory update on its endometrial cancer program. This update …

Published: Dec. 4, 2024, 8:10 a.m.
Read Full Article
Endometriosis, fibroids and heavy periods: long-term research supports treatment decisions - NIHR Evidence

Endometriosis, fibroids and heavy periods: long-term research supports treatment decisions NIHR Evidence

Published: Dec. 4, 2024, 8 a.m.
Read Full Article
Your top stories on Wednesday: FF, FG to push for talks with Independents; Dublin-Navan rail line to cost €3bn - The Irish Times

Your top stories on Wednesday: FF, FG to push for talks with Independents; Dublin-Navan rail line to cost €3bn The Irish Times

Published: Dec. 4, 2024, 7:41 a.m.
Read Full Article
New research links depression to more painful periods - Fast Company

New research links depression to more painful periods Fast Company

Published: Dec. 3, 2024, 9:02 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!